BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang YZ, Yao JN, Zhang LF, Wang CF, Zhang XX, Gao B. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. World J Gastroenterol 2019; 25(24): 3044-3055 [PMID: 31293340 DOI: 10.3748/wjg.v25.i24.3044]
URL: https://www.wjgnet.com/1007-9327/full/v25/i24/3044.htm
Number Citing Articles
1
Feng Tang, Yadi Xu, Bing Zhao. NLRC5: new cancer buster?Molecular Biology Reports 2020; 47(3): 2265 doi: 10.1007/s11033-020-05253-5
2
L. V. Topchieva, I. V. Kurbatova, O. P. Dudanova, A. V. Vasilyeva, G. A. Zhulay. Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease ProgressionBiology Bulletin 2024; 51(5): 1271 doi: 10.1134/S1062359024607742
3
Shaghayegh Khanmohammadi, Bruno Ramos-Molina, Mohammad Shafi Kuchay. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptorsDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(7): 102788 doi: 10.1016/j.dsx.2023.102788
4
Bhawna Chuphal, Umesh Rai, Brototi Roy. Teleost NOD-like receptors and their downstream signaling pathways: A brief reviewFish and Shellfish Immunology Reports 2022; 3: 100056 doi: 10.1016/j.fsirep.2022.100056
5
Chang Xu, Liangchang Li, Chongyang Wang, Jingzhi Jiang, Li Li, Lianhua Zhu, Shan Jin, Zhehu Jin, Jung Joon Lee, Guanhao Li, Guanghai Yan. Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathwaysJournal of Ginseng Research 2022; 46(4): 550 doi: 10.1016/j.jgr.2021.10.001
6
Liu Shi, Li Zhou, Ming Han, Yu Zhang, Yang Zhang, Xiao-Xue Yuan, Hong-Ping Lu, Yun Wang, Xue-Liang Yang, Chen Liu, Jun Wang, Pu Liang, Shun-Ai Liu, Xiao-Jing Liu, Jun Cheng, Shu-Mei Lin. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathwaysWorld Journal of Gastroenterology 2023; 29(18): 2798-2817 doi: 10.3748/wjg.v29.i18.2798
7
Jinghua Luo, Zhenhua Yao, Chunfeng Ye, Yanling Liu. Genome-wide analysis of RNA-binding protein co-expression with alternative splicing events in acute respiratory distress syndrome following hematopoietic stem cell transplantationMedicine 2023; 102(32): e34599 doi: 10.1097/MD.0000000000034599
8
Jie-quan Wang, Ya-ru Liu, Quan Xia, Ruo-nan Chen, Jun Liang, Qing-rong Xia, Jun Li. Emerging Roles for NLRC5 in Immune DiseasesFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01352
9
Shuang Lv, Yiming Li, Bojian Sun, Yu Jing, Xing Wang, Zhanqing Gu, Bailiang Wang, Cheng Xiao. Association of RIPK1 and RIPK2 Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Han PopulationThe Application of Clinical Genetics 2024; : 159 doi: 10.2147/TACG.S472418
10
Bo Wang, Yan Wu, Zhuowang Ge, Xuan Zhang, Yexiang Yan, Yuquan Xie. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathwayBiochemical and Biophysical Research Communications 2020; 528(3): 545 doi: 10.1016/j.bbrc.2020.05.151
11
Chen Sun, Yuqing Shen, Piaopiao Liu, Yi Shen, Yue Hu, Ping Li, Ying Zhang, Fengqin Miao, Jianqiong Zhang. NLRC5 Deficiency Reduces LPS-Induced Microglial Activation via Inhibition of NF-κB Signaling and Ameliorates Mice’s Depressive-like BehaviorInternational Journal of Molecular Sciences 2023; 24(17): 13265 doi: 10.3390/ijms241713265
12
Tao Jiang, Xiaojin Chen, Wanzhi Yang, Ning Li, Jinhong Xu, Yang Lu, Sisi Zhang, Shuihong Yu, Yongxia Li. Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and in vitro Experiments to Explore the Mechanism of Asiatic Acid Inhibiting Acetaldehyde-Induced Activation of Hepatic Stellate CellsNatural Product Communications 2023; 18(8) doi: 10.1177/1934578X231194127
13
Wen-Qing Li, Wen-Hao Liu, Die Qian, Jia Liu, Shi-Qiong Zhou, Lei Zhang, Wei Peng, Li Su, Hong Zhang. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.962525